IGBA position on identification of biological, including biosimilar medicines (2018 update of facts & figures)
Biosimilar Medicines Reading List
The impact of SPC Manufacturing Waiver on jobs, competitiveness & patient access to medicines
16th Biosimilar Medicines Conference
14th Legal Affairs Conference
17th Regulatory and Scientific Affairs Conferenc
11th Medicines for Europe Pharmacovigilance Conference
IGBA 2017 achievements – Adrian van den Hoven
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.Ok
